Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance (ENDURO)
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance in Athletes
Sponsor: Amazentis SA
A NA clinical study on Healthy, this trial is completed. The trial is conducted by Amazentis SA and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2023 — Sep 2023 [monthly]
Active Not Recruiting NA
-
Apr 2023 — Jul 2023 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Jan 2023 — Apr 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2022 — Jan 2023 [monthly]
Recruiting NA
-
Nov 2021 — Jun 2022 [monthly]
Recruiting NA
-
Sep 2021 — Nov 2021 [monthly]
Recruiting NA
-
May 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — May 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Amazentis SA
- Australian Catholic University
For direct contact, visit the study record on ClinicalTrials.gov .